DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Medically reviewed & updated
Medically reviewed by the HealthVetted Medical Board
Eczema, in its most common form, is atopic dermatitis — a chronic, relapsing inflammatory skin disease that makes the skin dry, intensely itchy, and prone to red or discolored, scaly patches. It is not contagious, it tends to flare and settle over time, and for most people it can be well controlled with daily skin care and the right medications.
"Eczema" is an umbrella term for several conditions that inflame the skin, but in everyday use it usually means atopic dermatitis (AD) — by far the most common type. Atopic dermatitis is a long-term (chronic) condition driven by a combination of a weakened skin barrier and an overactive immune response. When the barrier leaks moisture and lets in irritants, allergens, and microbes, the immune system reacts with inflammation. That inflammation produces the classic cycle: dryness, itch, scratching, and more barrier damage (the "itch–scratch cycle") (NIH/NIAMS; StatPearls).
Atopic dermatitis is part of a group of related allergic conditions called the atopic triad — eczema, asthma, and allergic rhinitis (hay fever). In children, AD often appears first and may be followed by food allergies, asthma, or hay fever later, a pattern clinicians call the "atopic march" (StatPearls).
The condition is genuinely common. AD affects roughly 1 in 5 children (about 13–20%) and around 7–10% of adults in the United States, making it one of the most frequent chronic skin diseases (AAD; NIH/NIAMS; National Health Interview Survey). It often begins in infancy or early childhood, though it can start at any age. In ICD-10 coding, atopic dermatitis falls under L20 (with L20.9 used for unspecified atopic dermatitis).
There is no single cause. Atopic dermatitis results from an interaction of genetics, immune dysregulation, a defective skin barrier, and environmental triggers (StatPearls; NIH).
Skin barrier defects. A major genetic contributor is a mutation in the *filaggrin* (FLG) gene, a protein essential for forming a healthy outer skin barrier. Filaggrin loss-of-function mutations are a well-established risk factor for AD and are associated with earlier, more persistent, and more severe disease (StatPearls). A weak barrier loses water (leading to dryness) and lets in allergens and bacteria.
Immune dysregulation. In AD, the immune system shifts toward a "type 2" inflammatory response involving signaling molecules such as interleukin-4 (IL-4) and interleukin-13 (IL-13). These cytokines drive inflammation and itch and are the direct targets of several modern medications.
Who's at risk. Key risk factors include:
Common flare triggers include dry skin and low humidity, soaps and harsh detergents, fragrances, wool or rough fabrics, heat and sweating, stress, certain skin infections, and, in some people, specific allergens. Triggers vary widely from person to person.
The hallmark symptoms of atopic dermatitis are intense itch (pruritus) and dry, inflamed skin. Itch is often the most distressing feature and can disrupt sleep.
Typical signs include:
Location matters and shifts with age:
The condition is relapsing: periods of flare (worsening) alternate with periods of remission (clearer skin).
There is no single blood test or biopsy that confirms atopic dermatitis. Diagnosis is clinical — a doctor or dermatologist makes it based on the appearance and distribution of the rash, the history of itch, and personal or family history of atopy (StatPearls; AAD).
Diagnostic criteria. Clinicians and researchers often use structured criteria to standardize diagnosis:
Supporting tests are used to rule out other conditions or identify triggers, not to confirm AD itself:
Severity is graded by how much body surface is affected, intensity of signs, itch, and impact on sleep and quality of life. Validated tools such as EASI (Eczema Area and Severity Index) and SCORAD are used in specialist care and clinical trials.
Treatment follows a stepwise approach, matched to severity. The foundation — good daily skin care — applies to everyone, and stronger therapies are added as needed (AAD guidelines).
When daily care is not enough, prescription treatments are added in roughly this order:
Antibiotics are reserved for clearly infected eczema, not routine flares.
Atopic dermatitis usually cannot be fully prevented, especially when there is a strong genetic or family history. But flares can often be reduced and long-term control is realistic for most people.
Day-to-day prevention of flares rests on consistent barrier care: moisturizing daily even when skin looks clear, avoiding known triggers, gentle bathing, and treating early signs of a flare promptly. Proactive (maintenance) therapy — applying a topical anti-inflammatory (such as a TCI or steroid) a couple of times a week to areas that frequently flare — is an evidence-based strategy to keep skin calm between episodes.
In infants at high risk (strong family history), there has been interest in early, regular emollient use to try to prevent AD, but study results have been mixed and routine emollient prophylaxis is not firmly established as preventive. Discuss individualized prevention with a pediatrician or dermatologist.
Managing the broader picture matters too: sleep, stress, and mental health are all affected by chronic itch, and addressing them is part of comprehensive care.
See a clinician if eczema is not improving with good skin care and OTC measures, if it is interfering with sleep, school, work, or daily life, or to get an accurate diagnosis and a treatment plan.
Seek prompt medical care for red flags of infection or complications:
Anyone with signs of a serious or spreading infection should be evaluated the same day or sent for emergency care.
For most people, the long-term outlook is good. Atopic dermatitis is a chronic, relapsing condition rather than a steadily progressive one, and it is highly manageable with modern treatment.
In children, AD frequently improves with age; many children see their eczema become milder or clear during childhood or adolescence, though "outgrowing" it completely is not guaranteed. Some people have a persistent or recurring course into adulthood, and a minority experience adult-onset disease. Even when AD persists, today's expanding range of treatments — from improved topicals to targeted biologics and JAK inhibitors — means severe, poorly controlled disease is far less common than in the past (AAD; NIH/NIAMS).
The main burdens are itch, sleep disruption, skin infections, and effects on quality of life and mental health. With consistent skin care, trigger management, and appropriate medication, most people achieve good control and lead full, active lives.
Is eczema contagious? No. Atopic dermatitis cannot be caught from or passed to another person. It is driven by genetics, the immune system, and the skin barrier — not by an infectious organism. (A secondary skin *infection* on top of eczema can be contagious, but the eczema itself is not.)
Will my child grow out of eczema? Often, eczema improves significantly with age, and many children have much milder or clear skin by their teens. However, it can persist or return later in life, so it's best to focus on good control now rather than waiting for it to disappear.
What's the difference between eczema and psoriasis? Both cause red or discolored, scaly patches, but they differ. Eczema is usually intensely itchy, tends to appear in skin creases, and is linked to allergies and asthma. Psoriasis typically causes thicker, well-defined plaques with silvery scale on areas like the elbows, knees, and scalp, and is often less itchy. A dermatologist can distinguish them, occasionally with a biopsy.
Are topical steroids safe for eczema? Used correctly — the right potency for the right body area, for appropriate periods — topical corticosteroids are effective and safe and remain first-line anti-inflammatory therapy. The main risk, skin thinning, comes from prolonged overuse of stronger steroids on thin skin (like the face). Steroid-free options such as topical calcineurin inhibitors and crisaborole are available for sensitive areas and long-term use. Follow your clinician's instructions on amount and duration.
Does diet cause eczema? For most people, diet is not the cause, and broad food avoidance is not recommended and can be harmful, especially in children. Some individuals — more often young children with moderate-to-severe AD — do have food allergies that can trigger flares. Testing and any dietary changes should be guided by a clinician, because positive allergy tests do not by themselves prove a food is worsening the eczema.
---
*This page is for general education and is not medical advice. Atopic dermatitis varies from person to person; talk with a qualified healthcare professional about diagnosis and treatment that's right for you.*
No. Eczema, including atopic dermatitis, is not contagious—you cannot catch it from or pass it to another person through skin contact. It develops from a combination of genetic skin-barrier differences, immune system activity, and environmental triggers. However, eczema-affected skin can become infected with bacteria or viruses, and those infections can spread, so any oozing, pus, or yellow crusting should be evaluated by a clinician.
Eczema is an umbrella term for several conditions that cause inflamed, itchy skin, including contact dermatitis, dyshidrotic eczema, and seborrheic dermatitis. Atopic dermatitis is the most common type of eczema. So while all atopic dermatitis is eczema, not all eczema is atopic dermatitis. In everyday conversation the two terms are often used interchangeably, but atopic dermatitis specifically refers to the chronic, allergy-associated form.
Common triggers include dry or cold air, sweating and heat, harsh soaps, fragrances, and detergents, rough fabrics such as wool, stress, and tobacco smoke. Some people also flare with certain allergens like dust mites, pollen, pet dander, or, in some children, specific foods. Triggers vary from person to person, so identifying and avoiding your individual triggers—alongside consistent moisturizing—is a key part of managing flares.
There is no cure for atopic dermatitis, but it can usually be well controlled. Many children improve significantly or outgrow it as they age, while others have a chronic, relapsing course into adulthood. The goal of treatment is to reduce itching and inflammation, heal flares, and lengthen the time between them through daily moisturizing, trigger avoidance, and medications when needed. Work with a clinician to build a long-term management plan.
Diagnosis is clinical—there is no single confirmatory test. A clinician examines the skin and reviews your history, looking for chronic or recurring itch, the typical rash pattern for your age, and a personal or family history of eczema, asthma, or hay fever. Allergy testing, blood tests, or a skin biopsy may be used to rule out other conditions rather than to confirm eczema itself.
Dermatologists generally recommend thick, fragrance-free moisturizers—ointments and creams hold moisture better than thin lotions. Look for products with few preservatives and ingredients like ceramides, petrolatum, or glycerin. Apply liberally at least once or twice daily, and especially within a few minutes of bathing to lock in moisture. The single best choice is the one you will use consistently; ask a clinician or pharmacist for guidance on options suited to your skin.
This page is for general information and is not medical advice. Always consult a qualified clinician about diagnosis and treatment. Individual results vary.